SA
ONC logo
BeOne Medicines AG(ONC)
Closing price · checked 8:34 PM ETAbout this dataData status
$390.94▼-8.76 (-2.19%)
Extended:$390.94+0.00 (+0.00%)· 8:34 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

BeOne Medicines AG (ONC)

R&D Expenses

$2.43B

TTM · Period ending: · USD

ONC logo

ONC R&D Expenses

Latest reported$2.43B
ONC R&D Expenses ($13.46M → $2.43B)
High-resolution chart · PNG

What is r&d expenses?

Research and development spending.

ONC r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

BeOne Medicines AG R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)Change
2,145,868,000+9.86%
1,953,295,000+9.82%
1,778,594,000+8.42%
1,640,508,000+12.42%
1,459,239,000+12.69%
1,294,877,000+39.63%
927,338,000+36.57%
679,005,000+152.40%
269,018,000+174.42%
98,033,000+68.30%
58,250,000+166.44%
21,862,000+62.39%
13,463,000—

Frequently asked questions: ONC r&d expenses

What is BeOne Medicines AG (ONC)'s current r&d expenses?

BeOne Medicines AG (ONC)'s latest reported r&d expenses (TTM) is $2.43B as of Sep 30, 2026. Research and development spending.

How much historical r&d expenses data is available for ONC?

Stock Alarm Pro provides 13 dated annual fiscal periods observations for BeOne Medicines AG (ONC)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ONC's r&d expenses to peers or set an alert?

You can open ONC's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ONC delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.